Researchers improve severe asthma care through new, antibody-based treatment

(McMaster University) Patients with severe asthma often require high doses of steroid-based treatments that can significantly impair their quality of life. This new drug is the only therapy that has been proven to be effective in well-established clinical trials to help reduce doses of steroid-based treatments such as prednisone for those with severe asthma.